Combination of GH secretagogues and PDE4 inhibitors for the treatment of Alzheimer's disease

Details for Australian Patent Application No. 2004226698 (hide)

Owner Merck Sharp & Dohme Limited

Inventors Castro Pineiro, Jose Luis

Agent Spruson & Ferguson

Pub. Number AU-A-2004226698

PCT Pub. Number WO2004/087157

Priority 0307863.1 04.04.03 GB

Filing date 1 April 2004

Wipo publication date 14 October 2004

International Classifications

A61K 031/454

A61K 038/05 Medicinal preparations containing peptides - Dipeptides

A61K 031/437

A61K 031/4985 - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

A61K 031/4164 - 1,3-Diazoles

A61K 031/4709 - Non-condensed quinolines containing further heterocyclic rings

A61K 031/277

A61K 031/00

A61K 031/4375

A61K 031/438 - the ring being spiro-condensed with carbocyclic or heterocyclic ring systems

A61K 031/55 - having seven-membered rings, e.g. azelastine, pentylenetetrazole

Event Publications

22 September 2005 PCT application entered the National Phase

  PCT publication WO2004/087157 Priority application(s): WO2004/087157

13 December 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004226701-Self-aligning tissue growth guide

2004226697-Histamine binding compounds for treatment method for disease conditions mediated by neutrophils